Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001104659-18-031769
Filing Date
2018-05-09
Accepted
2018-05-09 17:08:22
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A a18-12281_13sctoia.htm SC TO-I/A 179749
2 EX-99.(A)(1)(XIII) a18-12281_13ex99da1xiii.htm EX-99.(A)(1)(XIII) 72480
3 EX-99.(A)(1)(XIV) a18-12281_13ex99da1xiv.htm EX-99.(A)(1)(XIV) 5237
4 GRAPHIC g1228113mo03i001.jpg GRAPHIC 3140
5 GRAPHIC g1228113mqi001.jpg GRAPHIC 1915
  Complete submission text file 0001104659-18-031769.txt   266244
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filed by) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Subject) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-87819 | Film No.: 18819337
SIC: 2834 Pharmaceutical Preparations